TEST UND MEDIKAMENT

European patent · EP3094338 · In force

Register entry

Publication number
EP3094338
Application number
EP15701244
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 16, 2015
Published
Nov 23, 2016
Granted
Apr 13, 2022
Protection ends at the latest
Jan 15, 2035
Next annual fee due
Jan 31, 2027
IPC classes
A61K 35/76 (2015.01)
C12N 7/04 (2006.01)
Priority
GB 201400752 16.01.2014
PCT application
PCT/GB2015/050094 16.01.2015
PCT publication
WO2015/107357 23.07.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 16, 2026

    Next annual fee due on

    Next annual fee due on
    31.01.2026 → 31.01.2027

    Published in Swissreg on 16.07.2026

  2. Feb 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.01.2025 → 31.01.2026

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Mar 7, 2023

    Change

    Published in Swissreg on 07.03.2023

  5. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  6. Jun 3, 2022

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 03.06.2022

  7. Apr 13, 2022

    Granted

    Published in Swissreg on 13.04.2022

Parties

Inventor

EASTON, Andrew J.

Coventry Warwickshire CV4 7AL, GB

DIMMOCK, Nigel J.

Coventry Warwickshire CV4 7AL, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.